Cargando…
Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres
Treatment with monoclonal antibodies was associated with improved survival in COVID-19 after lung transplantation (LTx). Age was a negative independent predictor of survival in this cohort of 133 COVID-19 cases after LTx. https://bit.ly/3kx5CBw
Autores principales: | Gottlieb, Jens, Kolditz, Martin, Gade, Nils, Welte, Tobias, Kneidinger, Nikolaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301052/ https://www.ncbi.nlm.nih.gov/pubmed/35618274 http://dx.doi.org/10.1183/13993003.00124-2022 |
Ejemplares similares
-
Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation: a two center cohort study during the omicron era
por: Gottlieb, Jens, et al.
Publicado: (2023) -
Safety and efficacy of outpatient bronchoscopy in lung transplant recipients - a single centre analysis of 3,197 procedures
por: Rademacher, Jessica, et al.
Publicado: (2014) -
Adherence is associated with a favorable outcome after lung transplantation
por: Bertram, Anna, et al.
Publicado: (2019) -
Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study
por: Kneidinger, Nikolaus, et al.
Publicado: (2022) -
Pleural infection caused by Mycobacterium kansasii in a patient after lung transplantation
por: Plank, Pia Maria, et al.
Publicado: (2023)